CA2222595A1 - Microelements a usage therapeutique et leurs procedes d'obtention et d'utilisation - Google Patents

Microelements a usage therapeutique et leurs procedes d'obtention et d'utilisation Download PDF

Info

Publication number
CA2222595A1
CA2222595A1 CA002222595A CA2222595A CA2222595A1 CA 2222595 A1 CA2222595 A1 CA 2222595A1 CA 002222595 A CA002222595 A CA 002222595A CA 2222595 A CA2222595 A CA 2222595A CA 2222595 A1 CA2222595 A1 CA 2222595A1
Authority
CA
Canada
Prior art keywords
microdevices
suspension
microdevice
marker
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002222595A
Other languages
English (en)
Inventor
Mauro Ferrari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2222595A1 publication Critical patent/CA2222595A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6957—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a device or a kit, e.g. stents or microdevices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur une suspension de microéléments à usage thérapeutique obtenus par des techniques de microproduction d'une forme donnée et d'une taille uniforme de l'ordre de 100 nm à 10 Am, et sur lesdites techniques.
CA002222595A 1995-06-07 1996-06-07 Microelements a usage therapeutique et leurs procedes d'obtention et d'utilisation Abandoned CA2222595A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48176095A 1995-06-07 1995-06-07
US08/481,760 1995-06-07

Publications (1)

Publication Number Publication Date
CA2222595A1 true CA2222595A1 (fr) 1996-12-19

Family

ID=23913282

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002222595A Abandoned CA2222595A1 (fr) 1995-06-07 1996-06-07 Microelements a usage therapeutique et leurs procedes d'obtention et d'utilisation

Country Status (5)

Country Link
EP (1) EP0832446A1 (fr)
JP (1) JPH11507913A (fr)
AU (1) AU6104896A (fr)
CA (1) CA2222595A1 (fr)
WO (1) WO1996041236A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
IL133672A0 (en) * 1997-06-27 2001-04-30 Vivorx Pharmaceuticals Inc Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US7344499B1 (en) 1998-06-10 2008-03-18 Georgia Tech Research Corporation Microneedle device for extraction and sensing of bodily fluids
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6355270B1 (en) * 1999-01-11 2002-03-12 The Regents Of The University Of California Particles for oral delivery of peptides and proteins
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US9302903B2 (en) 2000-12-14 2016-04-05 Georgia Tech Research Corporation Microneedle devices and production thereof
AU2002231207A1 (en) 2000-12-21 2002-07-01 Biovalve Technologies, Inc. Microneedle array systems
US8361037B2 (en) 2001-09-19 2013-01-29 Valeritas, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
WO2003024508A2 (fr) 2001-09-21 2003-03-27 Biovalve Technologies, Inc. Amenagements de micro-aiguilles activees par pression de gaz, systemes et procedes correspondants
US20080112886A1 (en) * 2006-09-08 2008-05-15 The Regents Of The University Of California Engineering shape of polymeric micro- and nanoparticles
EP2856259B1 (fr) * 2012-05-30 2018-12-26 The Regents of The University of California Dispositifs de libération d'agent bio-actif et procédés de fabrication et d'utilisation des ceux-ci
WO2024123891A1 (fr) * 2022-12-07 2024-06-13 The University Of North Carolina At Chapel Hill Office Of Technology Commercialization Compositions de micro-organismes modifiés et leurs applications

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419340A (en) * 1969-03-24 1983-12-06 University Of Delaware Controlled release of anticancer agents from biodegradable polymers
JPS52109926A (en) * 1976-02-25 1977-09-14 Fuji Photo Film Co Ltd Metallic image forming material
JPS61187237A (ja) * 1985-02-14 1986-08-20 Toshiba Corp パタ−ン形成方法
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US4951675A (en) * 1986-07-03 1990-08-28 Advanced Magnetics, Incorporated Biodegradable superparamagnetic metal oxides as contrast agents for MR imaging
US5219554A (en) * 1986-07-03 1993-06-15 Advanced Magnetics, Inc. Hydrated biodegradable superparamagnetic metal oxides
US5069216A (en) * 1986-07-03 1991-12-03 Advanced Magnetics Inc. Silanized biodegradable super paramagnetic metal oxides as contrast agents for imaging the gastrointestinal tract
US4925678A (en) * 1987-04-01 1990-05-15 Ranney David F Endothelial envelopment drug carriers
US5527528A (en) * 1989-10-20 1996-06-18 Sequus Pharmaceuticals, Inc. Solid-tumor treatment method
DE4004430A1 (de) * 1990-02-09 1991-08-14 Schering Ag Aus polyaldehyden aufgebaute kontrastmittel
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use

Also Published As

Publication number Publication date
WO1996041236A1 (fr) 1996-12-19
EP0832446A1 (fr) 1998-04-01
AU6104896A (en) 1996-12-30
JPH11507913A (ja) 1999-07-13

Similar Documents

Publication Publication Date Title
US6107102A (en) Therapeutic microdevices and methods of making and using same
Ahmadi et al. Stimulus-responsive sequential release systems for drug and gene delivery
Ren et al. Role of liposome size, surface charge, and PEGylation on rheumatoid arthritis targeting therapy
Lane et al. Physical chemistry of nanomedicine: understanding the complex behaviors of nanoparticles in vivo
Mohammadi et al. Nanomaterials engineering for drug delivery: a hybridization approach
Anajafi et al. Polymersome-based drug-delivery strategies for cancer therapeutics
Praetorius et al. Engineered nanoparticles in cancer therapy
Toshio et al. Specific delivery of mitomycin c to the liver, spleen and lung: Nano-and m1crospherical carriers of gelatin
Marcucci et al. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress
Kato Encapsulated drugs in targeted cancer therapy
CA2222595A1 (fr) Microelements a usage therapeutique et leurs procedes d'obtention et d'utilisation
US20050175541A1 (en) Enhanced drug delivery
Awad et al. Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy
JP2008542293A (ja) 超音波増強ナノ粒子媒介性薬物送達のためのエコー形成性マイクロバブルおよびマイクロエマルジョン
Fattal et al. Nanomedicine technology: current achievements and new trends
Gref et al. Poly (ethyleneglycol)-coated nanospheres: potential carriers for intravenous drug administration
Dube et al. Evaluation of doxorubicin-loaded 3-helix micelles as nanocarriers
US20050084456A1 (en) Functionalized particles
Pandey et al. Multifunctional patented nanotherapeutics for cancer intervention: 2010-onwards
JPH11507725A (ja) 診断適用のための微小加工デバイス
AU2004315592B2 (en) Targeted atherosclerosis treatment
Sinha et al. Biodegradable PEGylated microspheres and nanospheres
Harris et al. Multifunctional nanoparticles for cancer therapy
Uppalapati et al. Nanotechnological Advancements For The Theranostic Intervention In Anaplastic Thyroid Cancer: Current Perspectives And Future Direction
Lu et al. Targeted liposomes and micelles as carriers for cancer therapy

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead